01 2VERTEX PHARMS
02 30VERTEX PHARMS INC
01 328324242
01 32Blank
01 32Blank
01 322027-08-05
Patent Expiration Date : 2027-08-05
US Patent Number : 8324242
Drug Substance Claim :
Drug Product Claim :
Application Number : 211358
Patent Use Code : U-3424
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-05
Patent Expiration Date : 2027-08-05
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 8324242
Drug Substance Claim :
Drug Product Claim :
Application Number : 217660
Patent Use Code : U-4066
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-05
Patent Expiration Date : 2027-08-05
US Patent Number : 8324242
Drug Substance Claim :
Drug Product Claim :
Application Number : 206038
Patent Use Code : U-1911
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-05
Patent Expiration Date : 2027-08-05
US Patent Number : 8324242
Drug Substance Claim :
Drug Product Claim :
Application Number : 207925
Patent Use Code : U-1311
Delist Requested :
Patent Use Description : METHOD OF TREATING CYS...
Patent Expiration Date : 2027-08-05
Patent Expiration Date : 2027-08-05
US Patent Number : 8324242
Drug Substance Claim :
Drug Product Claim :
Application Number : 207925
Patent Use Code : U-2527
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-05
Patent Expiration Date : 2027-08-05
US Patent Number : 8324242
Drug Substance Claim :
Drug Product Claim :
Application Number : 207925
Patent Use Code : U-1311
Delist Requested :
Patent Use Description : METHOD OF TREATING CYS...
Patent Expiration Date : 2027-08-05
Patent Expiration Date : 2027-08-05
US Patent Number : 8324242
Drug Substance Claim :
Drug Product Claim :
Application Number : 207925
Patent Use Code : U-2963
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-05
Patent Expiration Date : 2027-08-05
US Patent Number : 8324242
Drug Substance Claim :
Drug Product Claim :
Application Number : 203188
Patent Use Code : U-1906
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-05
Patent Expiration Date : 2027-08-05
US Patent Number : 8324242
Drug Substance Claim :
Drug Product Claim :
Application Number : 207925
Patent Use Code : U-1906
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-05
Patent Expiration Date : 2027-08-05
DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US Patent Number : 8324242
Drug Substance Claim :
Drug Product Claim :
Application Number : 218730
Patent Use Code : U-4090
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-08-05
